Exelis Inc. (NYSE: XLS)


The firm is investigating the Board of Directors of Exelis, Inc. ("Exelis" or the "Company") (XLS) for potential breaches of fiduciary duties in connection with the sale of the Company to Harris Corporation ("Harris") (HRS) for approximately $4.75 billion in a cash and stock transaction. The Company's stockholders will only receive $16.625 in cash and 0.1025 of a share of Harris for each share of Exelis common stock they own. This equates to a value of about $23.75 per share.

The investigation focuses on whether Exelis' Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Exelis' shareholders.

If you are a current shareholder and would like to discuss your options of exercising your rights as a shareholder, which include ensuring that the company is getting the highest possible price for the company, and that the board of directors will act in the best interest of the shareholders, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.

Personal Information
Name:
Phone #:
E-mail Address:
Stock Information
Do you currently own the stock? Yes   No
Purchase Date:
Quantity Purchased:
Purchase Price Per Share:

Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.